Clinical Trials Logo

Early Discharge clinical trials

View clinical trials related to Early Discharge.

Filter by:
  • None
  • Page 1

NCT ID: NCT06178172 Not yet recruiting - Pancreatitis, Acute Clinical Trials

Remote Home Monitoring in Mild Acute Pancreatitis

INTERACT
Start date: January 2, 2024
Phase: N/A
Study type: Interventional

Acute pancreatitis is an inflammation of the pancreas which causes abdominal pain and is the most common gastro-intestinal reason for acute hospitalization in Western countries. Because care for patients with a mild acute pancreatitis is mostly supportive, providing this care in the home environment may be feasible with the use of remote monitoring. This might reduce the demand for hospital beds and allow patients to benefit from recovering in their home environment. Therefore, the objective of this single center study is to assess the feasibility of a novel care program in which patients with a predicted mild course of acute pancreatitis are discharged early with remote home monitoring. Patients, with a predicted mild course of acute pancreatitis. Patients with prior acute pancreatitis within 3 months or a chronic pancreatitis are excluded from participation. Patients should be ≥18 years of age. The goal is to include a total of 70 patients. After at least 48 hours of hospital admission, patients are discharged early with the use of remote home monitoring. At home, patients receive guidance for the management of pain, nutrition and pancreatitis-related complaints by a daily phone call from a nurse from the Virtual Monitoring Centre (VMC). The pancreatitis-related complaints, intake of fluids and food, pain and the use of analgesics are assessed using short questionnaires in a smartphone app. Core temperature is monitored using an ear thermometer and a wearable sensor measures heart rate, respiratory rate, posture and movement every 5 minutes. Remote home monitoring will continue for at least 4 days. The main study objective is to assess the feasibility of the novel care program. Feasibility is determined by, patient satisfaction and actual use of the novel care program. The secondary study objective is to describe clinical outcomes of patients in the novel care program.

NCT ID: NCT04126980 Completed - Readmission Clinical Trials

Early Discharged Lumbar Spine Fusion Reduced Postoperative Readmissions: A Follow-up Study in a National Cohort

Start date: September 11, 2018
Phase:
Study type: Observational

This study undertake to determine the effects of ED on readmissions and reoperations in lumbar fusion. The study enrolled patients who underwent lumbar fusion surgery at age 50-70 years from a national database, and grouped them into an ED group or a comparison group. All patients were then followed-up for 180 days after the indexed surgery of lumbar fusion.

NCT ID: NCT03070457 Not yet recruiting - Morbid Obesity Clinical Trials

Safety of an Early Discharge Protocol After Sleeve Gastrectomy

Start date: March 1, 2017
Phase: N/A
Study type: Interventional

Evaluate the safety and efficacy of an early discharge protocol (23 hours, overnight stay) after scheduled sleeve gastrectomy.

NCT ID: NCT02023983 Completed - Clinical trials for Coronary Artery Disease

Verification of the Safety of Early Discharge in Patients After Acute ST-segment Myocardial Infarction

Start date: October 2013
Phase: N/A
Study type: Interventional

The aim of the study is to prove that early discharge (within 72 hours) in selected group of patients after myocardial infarction with elevations of ST-segment is feasible and safe